Kaneko Mika

カネコミカ | Kaneko Mika

Affiliation and department：
Homepage URL (1)： https://nrid.nii.ac.jp/ja/nrid/1000000323163/

Research field (4)： Evolutionary biology , Functional biochemistry , Structural biochemistry , Genetics

Research keywords (8)： Antibody Drug Development , Antibody engineering , 分子進化学 , 糖鎖工学 , 糖鎖生物学 , melecular evolution , glycoengineering , glycobiology

Research theme for competitive and other funds (16)：

2021 - 2024 Development and characterization of cancer-specific monoclonal antibodies against tumor-associated glycoproteins.
2017 - 2020 Development and characterization of a cancer-specific monoclonal antibody against a tumor-associated sialoglycoprotein.
2014 - 2017 Development and characterization of a cancer-specific monoclonal antibody (CasMab) against podoplanin
2011 - 2012 Regulatory mechanisms of glycosyltransferase genes which synthesizetumor specific glycan on PDPN.
2005 - 2006 ヘパラン硫酸の糖鎖構造多様性による神経回路形成の制御

Show all

Papers (404)：

Miu Hirose, Hiroyuki Suzuki, Rena Ubukata, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. Development of specific anti-mouse atypical chemokine receptor 4 monoclonal antibodies. Biochemistry and biophysics reports. 2024. 40. 101824-101824
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Guanjie Li, Tomohiro Tanaka, Akira Ohkoshi, Manabu Kawada, Mika Kaneko, et al. Antitumor activities of anti-CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer. Oncology Reports. 2024. 52. 5
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Guanjie Li, Tomohiro Tanaka, Manabu Kawada, Akira Ohkoshi, Mika K. Kaneko, Yukio Katori, Yukinari Kato. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. International Journal of Molecular Sciences. 2024. 25. 17. 9190-9190
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. International journal of molecular sciences. 2024. 25. 15
Rena Ubukata, Hiroyuki Suzuki, Tomohiro Tanaka, Guanjie Li, Mika K Kaneko, Yukinari Kato. Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024

ｍore...

MISC (53)：

山田航大, 塩屋亮平, 金子美華, 西野耕平, 加藤幸成, 小迫英尊, 澤崎達也. 近接ビオチン化酵素AirID融合抗体を用いた膜タンパク質細胞外ドメイン相互作用解析. 日本生化学会大会プログラム・講演要旨集. 2022. 95回. 1P-209
田中智大, 大石智一, 川田学, 金子美華, 加藤幸成. 抗TROP2モノクローナル抗体TrMab-6の乳がんモデルに対する抗腫瘍効果. 日本癌学会学術総会抄録集(Web). 2021. 80th
金子美華, 大石智一, 川田学, 加藤幸成, 加藤幸成. 膵がんを標的としたコアフコース欠損型がん特異的抗ポドカリキシン抗体の開発. 日本生化学会大会(Web). 2021. 94th
細野ヒデキ, 大石智一, 淺野禎三, 金子美華, 川田学, 加藤幸成, 加藤幸成. 新規抗EpCAM抗体(EpMab-16)の大腸がんに対する抗腫瘍活性の評価. 日本生化学会大会(Web). 2021. 94th
七宮蓮, 武井潤子, 武井潤子, 大石智一, 川田学, 原田浩之, 金子美華, 加藤幸成, 加藤幸成. 新規抗EGFRモノクローナル抗体134-mG2aの口腔扁平上皮がん移植片モデルにおける抗腫瘍効果の検討. 日本癌学会学術総会抄録集(Web). 2021. 80th

ｍore...

Education (4)：

- 2000 The Graduate University for Advanced Studies
- 2000 The Graduate University for Advanced Studies Graduate School, Division of Life Science Genetics
- 1997 Soka University
- 1997 Soka University Faculty of Engineering Department of Bioengineering

Professional career (2)：

(BLANK) (The Graduate University for Advanced Studies)
(BLANK) (Soka University)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page